Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canadian drugs sales level off while R&D budgets fall

This article was originally published in Scrip

Executive Summary

Pharmaceutical sales grew just 1.7% in 2011 from Can$12.9 billion to Can$13.1 billion according to Canada's Patented Medicine Prices Review Board (PMPRB), which has the legal mandate of ensuring that medicines prices in Canada are not excessive. Indeed the increase in the total spend on medicines can be attributed to the introduction of new medicines rather than changes in prices.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC017848

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel